Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-08-14

Clinical Trial Update: A Study of E7080 in Subjects With Advanced Thyroid Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial update for E7080 in advanced thyroid cancer has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • E7080 (lenvatinib)

Snippet

Sponsor: Eisai Co., Ltd. | Conditions: Thyroid Cancer | Phase 2 | Status: COMPLETED | Results posted: 2020-08-14